Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease: a Pilot Study


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04932434

Organisation Name: University of California, San Francisco

Overal Status: Not yet recruiting

Start Date: August 2021

Last Update: July 20, 2021

Lead Sponsor: Joshua Woolley, MD/PhD

Brief Summary: The purpose of this study is to determine the safety, tolerability, and feasibility of psilocybin therapy for depression and anxiety in people with Parkinson's disease.

Conditions:
  • Parkinson Disease
  • Depression
  • Anxiety


Total execution time in seconds: 0.18166184425354